Lincoln Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE405C01035
NSEID: LINCOLN
BSEID: 531633

INR

493.25

-1.85 (-0.37%)

BSENSE

Dec 05

BSE+NSE Vol: 5.29 k

{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "493.25",
    "chg": -1.85,
    "chgp": "-0.37%",
    "dir": -1,
    "prev_price": "495.10",
    "mcapval": "987.97 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "5.29 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Lincoln Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharma-fallingrising-3742347",
        "imagepath": "",
        "date": "2025-12-03 00:30:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Lincoln Pharmaceuticals has been under pressure in recent trading sessions, with the stock losing value for two consecutive days and registering a cumulative decline of 2.45% over this period. The share price touched an intraday low of ₹496.15, marking a 2.25% drop from previous levels. Notably, the stock is trading just 1.72% above its 52-week low of ₹491, signalling proximity to its lowest valuation in the past year.</p>\n<p>This downward momentum contrasts sharply with the broader market, as the Sensex has posted positive returns over comparable periods. For instance, while Lincoln Pharma declined by 3.70% over the past week, the Sensex gained 0.65%. Similarly, over the last month, the stock fell 5.87%, whereas the benchmark index ro..."
      },
      {
        "title": "Lincoln Pharma. Sees Revision in Market Evaluation Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharma-upgraded-from-strong-sell-to-sell-by-marketsmojo-3737093",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharma_mojoScore_3737093.png",
        "date": "2025-11-30 10:24:43",
        "description": "Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions, prompting a reassessment of the company’s standing within its sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-momentum-shifts-amid-bearish-signals-3719579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3719579.png",
        "date": "2025-11-21 08:02:34",
        "description": "Lincoln Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a nuanced market assessment for this Pharmaceuticals & Biotechnology sector stock."
      },
      {
        "title": "Is Lincoln Pharma. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lincoln-pharma-technically-bullish-or-bearish-3716849",
        "imagepath": "",
        "date": "2025-11-20 08:10:21",
        "description": "As of 19 November 2025, the technical trend for Lincoln Pharma has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by several key indicators. The weekly MACD is mildly bullish, but the monthly MACD and KST are both bearish, indicating mixed signals. The moving averages on a daily basis are mildly bearish, and the Bollinger Bands show a sideways trend on the weekly chart while being mildly bearish on the monthly. Additionally, the Dow Theory indicates a mildly bullish stance on the weekly but remains mildly bearish on the monthly. Overall, the strength of the bearish sentiment is supported by the monthly indicators, despite some positive movement in the weekly timeframe...."
      },
      {
        "title": "Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-momentum-shifts-amid-mixed-indicator-signals-3717038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3717038.png",
        "date": "2025-11-20 08:02:04",
        "description": "Lincoln Pharmaceuticals has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. Recent market data reveals a mild transition in trend dynamics, with key technical parameters signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Lincoln Pharma. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lincoln-pharma-technically-bullish-or-bearish-3713792",
        "imagepath": "",
        "date": "2025-11-19 08:13:28",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating a bearish trend, the KST showing bearish signals on both weekly and monthly time frames, and the monthly Bollinger Bands reflecting a mildly bearish stance. Although the weekly MACD is mildly bullish, it is overshadowed by the overall bearish signals from other indicators. The Dow Theory also indicates a mildly bearish trend on the monthly chart, further supporting the bearish outlook...."
      },
      {
        "title": "Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-momentum-shifts-amid-bearish-signals-3714199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3714199.png",
        "date": "2025-11-19 08:02:47",
        "description": "Lincoln Pharmaceuticals has experienced a notable shift in its technical parameters, reflecting a transition in price momentum and mixed signals from key technical indicators. The stock’s current price stands at ₹529.05, slightly below its previous close of ₹531.90, with a day’s trading range between ₹527.60 and ₹534.55. This movement comes amid a broader technical trend adjustment from mildly bearish to bearish, signalling evolving market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lincoln Pharmaceuticals Shows Mixed Technical Trends Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-3710099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LincolnPharmace_technicaldot_3710099.png",
        "date": "2025-11-18 08:04:48",
        "description": "Lincoln Pharmaceuticals has recently revised its evaluation amid current market dynamics, with its stock price rising from the previous close. Over the past year, the company has faced a decline, contrasting with broader market gains. Despite short-term pressures, it has shown strong long-term performance compared to the Sensex."
      },
      {
        "title": "Why is Lincoln Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharma-fallingrising-3708165",
        "imagepath": "",
        "date": "2025-11-17 21:38:55",
        "description": "As of 17-Nov, Lincoln Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 538.40, which reflects a rise of Rs 13.25 or 2.52%. The stock has shown positive momentum, gaining 6.58% over the last two days and outperforming its sector by 2.24% today. It opened with a significant gain of 6.25% and reached an intraday high of Rs 557.95. However, despite these gains, the stock has a year-to-date decline of 31.93% and a one-year decline of 12.96%, indicating a challenging longer-term performance. Notably, there has been a decrease in investor participation, with delivery volume falling by 25.75% against the five-day average, which may suggest caution among investors.\n\nIn the broader market context, Lincoln Pharmaceuticals has outperformed the Sensex in the short term, with a one-week return of 3.22% compared to the Sensex's 1.69%. This indicates that while the stock is currently rising, it is doin..."
      }
    ],
    "total": 924,
    "sid": "294056",
    "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on December 07, 2019 for consider and approved draft scheme of amalgamation and withdrawal scheme approved by Board earlier",
      "source": "NSE",
      "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019 for Considered and Approved Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019",
      "source": "NSE",
      "caption": "Lincoln Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Lincoln Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"press release dated October 22, 2019 titled \"Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray. \".",
      "source": "NSE",
      "caption": "Lincoln Pharmaceuticals Limited - Press Release",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Lincoln Pharma. falling/rising?

2025-12-03 00:30:47

Recent Price Movement and Market Context

Lincoln Pharmaceuticals has been under pressure in recent trading sessions, with the stock losing value for two consecutive days and registering a cumulative decline of 2.45% over this period. The share price touched an intraday low of ₹496.15, marking a 2.25% drop from previous levels. Notably, the stock is trading just 1.72% above its 52-week low of ₹491, signalling proximity to its lowest valuation in the past year.

This downward momentum contrasts sharply with the broader market, as the Sensex has posted positive returns over comparable periods. For instance, while Lincoln Pharma declined by 3.70% over the past week, the Sensex gained 0.65%. Similarly, over the last month, the stock fell 5.87%, whereas the benchmark index ro...

Lincoln Pharma. Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-11-30 10:24:43

Lincoln Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This development comes amid a backdrop of subdued financial performance and challenging market conditions, prompting a reassessment of the company’s standing within its sector.

Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals

2025-11-21 08:02:34

Lincoln Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a nuanced market assessment for this Pharmaceuticals & Biotechnology sector stock.

Is Lincoln Pharma. technically bullish or bearish?

2025-11-20 08:10:21

As of 19 November 2025, the technical trend for Lincoln Pharma has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by several key indicators. The weekly MACD is mildly bullish, but the monthly MACD and KST are both bearish, indicating mixed signals. The moving averages on a daily basis are mildly bearish, and the Bollinger Bands show a sideways trend on the weekly chart while being mildly bearish on the monthly. Additionally, the Dow Theory indicates a mildly bullish stance on the weekly but remains mildly bearish on the monthly. Overall, the strength of the bearish sentiment is supported by the monthly indicators, despite some positive movement in the weekly timeframe....

Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Market Signals

2025-11-20 08:02:04

Lincoln Pharmaceuticals has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. Recent market data reveals a mild transition in trend dynamics, with key technical parameters signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.

Is Lincoln Pharma. technically bullish or bearish?

2025-11-19 08:13:28

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating a bearish trend, the KST showing bearish signals on both weekly and monthly time frames, and the monthly Bollinger Bands reflecting a mildly bearish stance. Although the weekly MACD is mildly bullish, it is overshadowed by the overall bearish signals from other indicators. The Dow Theory also indicates a mildly bearish trend on the monthly chart, further supporting the bearish outlook....

Lincoln Pharmaceuticals Technical Momentum Shifts Amid Mixed Indicator Signals

2025-11-19 08:02:47

Lincoln Pharmaceuticals has experienced a notable shift in its technical parameters, reflecting a transition in price momentum and mixed signals from key technical indicators. The stock’s current price stands at ₹529.05, slightly below its previous close of ₹531.90, with a day’s trading range between ₹527.60 and ₹534.55. This movement comes amid a broader technical trend adjustment from mildly bearish to bearish, signalling evolving market sentiment within the Pharmaceuticals & Biotechnology sector.

Lincoln Pharmaceuticals Shows Mixed Technical Trends Amid Market Challenges

2025-11-18 08:04:48

Lincoln Pharmaceuticals has recently revised its evaluation amid current market dynamics, with its stock price rising from the previous close. Over the past year, the company has faced a decline, contrasting with broader market gains. Despite short-term pressures, it has shown strong long-term performance compared to the Sensex.

Why is Lincoln Pharma. falling/rising?

2025-11-17 21:38:55

As of 17-Nov, Lincoln Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 538.40, which reflects a rise of Rs 13.25 or 2.52%. The stock has shown positive momentum, gaining 6.58% over the last two days and outperforming its sector by 2.24% today. It opened with a significant gain of 6.25% and reached an intraday high of Rs 557.95. However, despite these gains, the stock has a year-to-date decline of 31.93% and a one-year decline of 12.96%, indicating a challenging longer-term performance. Notably, there has been a decrease in investor participation, with delivery volume falling by 25.75% against the five-day average, which may suggest caution among investors. In the broader market context, Lincoln Pharmaceuticals has outperformed the Sensex in the short term, with a one-week return of 3.22% compared to the Sensex's 1.69%. This indicates that while the stock is currently rising, it is doin...

View All News

Announcement

Lincoln Pharmaceuticals Limited - Outcome of Board Meeting

09-Dec-2019 | Source : NSE

Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on December 07, 2019 for consider and approved draft scheme of amalgamation and withdrawal scheme approved by Board earlier

Lincoln Pharmaceuticals Limited - Outcome of Board Meeting

14-Nov-2019 | Source : NSE

Lincoln Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019 for Considered and Approved Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019

Lincoln Pharmaceuticals Limited - Press Release

22-Oct-2019 | Source : NSE

Lincoln Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 22, 2019, titled "press release dated October 22, 2019 titled "Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray. ".